Orphan drugs policies: a suitable case for treatment
Context Current orphan drug policies are unsatisfactory when viewed from almost all perspectives. Patients find that, although therapies are available for many rare conditions, access to care is sometimes restricted. Pharmaceutical manufacturers have responded to the incentives for research embodied...
| Veröffentlicht in: | The European Journal of Health Economics. - Springer Science + Business Media. - 15(2014), 4, Seite 335-340 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2014
|
| Zugriff auf das übergeordnete Werk: | The European Journal of Health Economics |
| Schlagworte: | Behavioral sciences Health sciences Economics Political science Business Law |
| Online verfügbar |
Volltext |